Medscape9d
The Glucagonostatic and Insulinotropic Effects of Glucagon-like Peptide 1 Contribute Equally to its Glucose-lowering Action
Objective—Glucagon-like peptide 1 (GLP-1) exerts beneficial antidiabetic actions via effects on pancreatic β- and α-cells. Previous studies have focused on the improvements in β-cell function ...
Medical Xpress20d
Glucagon-like peptide-1 receptor agonists tied to higher thyroid cancer risk in first year of treatment
Get Instant Summarized Text (Gist) Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are linked to an increased risk of thyroid cancer in the first year of treatment for type 2 diabetes ...
EurekAlert!9d
American Heart Month — Basic scientists seek to uncover the fundamentals of heart disease risk factors
Basic science researchers at the Johns Hopkins University School of Medicine are advancing heart health research by finding ...
Hosted on MSN10mon
GLP-1s Like Ozempic, Wegovy Don’t Substantially Increase Thyroid Cancer Risk, Study Suggests
Glucagon-like ... “does not support a causal association” between GLP-1 drugs and thyroid cancer. This came four months after the EMA raised a safety signal and said it’d look into whether ...
Ulster University2mon
Targeting glucagon-like peptides for the treatment of diabetes and obesity
Glucagon-like peptide-1 (GLP-1) and glucagon-like peptide-2 (GLP-2 ... Lafferty RA, Flatt PR, Gault VA, Irwin N. Does glucose-dependent insulinotropic polypeptide receptor blockade as well as agonism ...
The Victoria Advocate14d
ACCP Position Statement: "Ensuring the Appropriate Use of Glucagon-Like Peptide-1 Receptor Agonists"
Feb. 5, 2025 /PRNewswire/ -- The American College of Clinical Pharmacology ® (ACCP) published a recent Position Paper entitled "Ensuring the Appropriate Use of Glucagon-Like Peptide-1 Receptor ...